Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension
Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart, Jeanine Kamphuis, Jan Spijker, Annemarie van der Meij, Antoinette D. I. van Asselt, Marije aan het Rot, Robert A. Schoevers
Topics & Concepts
TolerabilityPlaceboMedicineAnesthesiaTreatment-resistant depressionRandomized controlled trialInternal medicineAdverse effectAntidepressantPathologyAlternative medicineHippocampusTreatment of Major DepressionTryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior